CLINICAL_TRIALS
trial_result
· 2026-03-05
Clinical Trial Update: Short Neoadjuvant Hemithoracic IMRT for MPM [Phase 1, Phase 2]
Summary
A completed Phase 1/2 trial evaluating short neoadjuvant hemithoracic IMRT for malignant pleural mesothelioma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Health Network, Toronto | Conditions: Malignant Pleural Mesothelioma | Phase 1, Phase 2 | Status: COMPLETED